NDUFB3 and thyroid gland papillary carcinoma: We performed lentivirus-mediated shRNA knockdown targeting human NDUFB3 in both BCPAP (papillary thyroid cancer cells) and C643 (anaplastic thyroid cancer cells) cell lines.